AI model to predict survival after early-onset colorectal cancer surgery
Part of Cancer, Digestive system clinical trials.
This study uses an artificial intelligence (AI) model to predict how long people with early-onset colorectal cancer may live after surgery. The goal is to help doctors and patients make better treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with early-onset colorectal cancer (EOCRC) that started before age 50 (or earlier in life).
- You had surgery to remove the cancer (such as a partial or total colectomy) and the cancer was stage I, II, or III (not spread to far parts of the body).
- You have no other current or past cancers (except maybe some skin cancers).
- You have survived at least 1 month after surgery and have follow-up medical records.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an artificial intelligence model to analyze test results from the fecal immunochemical test (FIT) to help find colon cancer early. You may benefit if you are 50-69 and had a positive FIT result as part of a screening program.
This trial tests whether artificial intelligence can help doctors better detect and classify growths in the colon during a colonoscopy. You may benefit from potentially more accurate results.
This study uses artificial intelligence to analyze tissue samples from your colorectal cancer surgery to help predict how you'll recover and what your long-term outlook might be. Researchers will examine your tumor tissue under a microscope to build a computer model that could help doctors personalize your care plan.
This study tests whether an artificial intelligence (AI) model can predict if colon or rectal cancer will spread to the liver. You will have a CT scan before surgery, and the AI will analyze the scan to see if it can forecast future liver metastasis.
This study is testing whether an artificial intelligence system can find very small amounts of leftover cancer (minimal residual disease) after treatment for rectal or esophageal cancer. If successful, this could help doctors detect a relapse earlier than current methods.
This trial is testing a computer model that helps doctors predict how difficult rectal cancer surgery will be, so they can choose the best approach. The study aims to improve surgical planning and outcomes for patients.
Hear when a new Colorectal cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.